Estándar de tratamiento en primera línea de cáncer de páncreas metastásico: ¿ABRAXANE-GEMCITABINA o FOLFIRINOX? - page 22

CONCLUSIONS
Can G-NP face to FOLFIRINOX in the same group of patients (very fit or super-fit
patients/without restrictions or limitations)?
Yes
Interesting “new” data (retrospective and from clinical practice, not randomized)
1st-line treatment with G-NP is effective and well tolerated in the real world
1st-line G-NP permits more 2
nd
- 3
rd
line treatment options than 1st-line FOLFIRINOX
(1st-line treatment with G-NP does not compromise subsequent treatment options)
1...,12,13,14,15,16,17,18,19,20,21 22
Powered by FlippingBook